FDA Warns of Counterfeit Diabetes Drug Infiltrating U.S. Supplies
TRENTON, NJ – The U.S. Food and Drug Administration (FDA) issued a warning on Thursday against counterfeit versions of Novo Nordisk’s diabetes drug, Ozempic, which have infiltrated the U.S. drug supply chain.…
